An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases.

Conditions:   Lupus Nephritis;   Immunoglobulin A Nephropathy;   Membranous Nephropathy Intervention:   Drug: povetacicept Sponsor:   Alpine Immune Sciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials